The Diabetes Monitor: Rezulin (Troglitazone) information.

Troglitazone (removed from the US market 3/21/00) WARNINGS From our sponsors: . From our sponsors: Hepatic Rare cases of severe idiosyncratic hepatocellular injury have been reported during marketed use (see ADVERSE REACTIONS). The hepatic injury is usually reversible, but very rare cases of hepatic failure, leading to death or liver transplant, have been reported. Injury has occurred after both ...